Replies to post #335010 on NorthWest Biotherapeutics Inc (NWBO)

[marzan]

BSB, you know well that there is no bad news or trial failure non sense. UK and Germany RAs have openly accepted the new endpoints and some kind of approval there is a given already 100% the moment TLD is released. Let us all stop talking about SEC 72hrs rule this and that. See Europe is ahead that has already approved PFE/BNTX vaccine today. This is the first time to my knowledge that FDA is lagging behind other countries particularly Europe in the drug approval process. FDA under Hahn is just screwed up. US is NOT a leader anymore in this political limbos. Assuming FDA/Canada approval is also in the bag, let us focus on future market cap valuation, warrant extension, uplisting to a better exchange, publication, TLD timelines, and of course partnership and/or b/o speculations.

[BetIsOn]

Hi BBB,

Do you remember LP said we already have a homerun previously? So the OS endpoint should be OK and the trial should at least approved partially if not fully approved. At that time we do not know the SAP has been changed to have multiple endpoints. It Looks like the OS endpoint is delayed to wait for all other end points load the bases in order to have chance to hit a grand.

Regards,

BetIOn

[WojD40]

Being 28 days late today, they are over five times as late as they normally are (median of lateness is 5 days). This is nowhere near the historical high of FORTY FOUR DAYS last May for filing the 10-Q.

I'll PM you the chart I made from the SEC filings because I can't seem to post pictures here.